Candel Therapeutics, Inc.CADLNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P67
Within normal range
Average
-7373.14%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | +100.0% |
| 2022 | -13046.40% | +36.0% |
| 2021 | -20395.20% | -85.8% |
| 2020 | -10975.20% | -52.5% |
| 2019 | -7195.20% | - |